QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Sulfuration of an Fe–N–C Catalyst Containing FexC/Fe Species to Enhance the Catalysis of Oxygen Reduction in Acidic Media and for Use in Flexible Zn–Air Batteries 期刊论文 Advanced Materials, 2018, 卷号: 30, 期号: 46, 页码: - 作者:  Qiao, Yueyang;  Yuan, Pengfei;  Hu, Yongfeng;  Zhang, Jianan*;  Mu, Shichun* 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/04 catalysis  flexible materials  iron–carbon species  zinc–air batteries   SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker. 期刊论文 BMB reports, 2018 作者:  Xu Liyun;  Lu Changchang;  Huang Yanyan;  Zhou Jihang;  Wang Xincheng 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/26 Circulations associated with cold pools in the Bohai Sea on the Chinese continental shelf 期刊论文 CONTINENTAL SHELF RESEARCH, 2017, 卷号: 137, 页码: 25-38 作者:  Zhou, Feng;  Huang, Daji;  Xue, Huijie;  Xuan, Jihang;  Yan, Tao 收藏  |  浏览/下载：4/0  |  提交时间：2019/08/19 Bohai Sea  Circulation  Cold pool  Cyclonic gyre  Lagrangian particle   Circulations associated with cold pools in the Bohai Sea on the Chinese continental shelf 期刊论文 CONTINENTAL SHELF RESEARCH, 2017, 卷号: 137, 页码: 25-38 作者:  Zhou, Feng;  Huang, Daji;  Xue, Huijie;  Xuan, Jihang;  Yan, Tao 收藏  |  浏览/下载：4/0  |  提交时间：2018/12/07 Bohai Sea  Circulation  Cold pool  Cyclonic gyre  Lagrangian particle   Changes of Piperacillin Resistance to Gram-negative Bacteria Isolated in a University Hospital 2004-2010 期刊论文 2012 INTERNATIONAL CONFERENCE ON FUTURE INFORMATION TECHNOLOGY AND MANAGEMENT SCIENCE & ENGINEERING (FITMSE 2012), 2012, 卷号: 14 作者:  Xu, Jiancheng;  Yao, Jihang;  Yao, Di;  Zhou, Qi 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Changes of Piperacillin Resistance to Gram-negative Bacteria Isolated in a University Hospital 2004-2010 会议论文 作者:  Zhou, Qi;  Xu, Jiancheng;  Yao, Jihang;  Yao, Di 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 piperacillin  beta-Lactamases  drug resistance  microbial  antimicrobials susceptibility test  drug monitoring